Sarah Holland
Direktor/Vorstandsmitglied bei Swiss Healthcare Licensing Group
Profil
Sarah Holland is currently the Director at Swiss Healthcare Licensing Group.
She previously worked as the Director-Global Brand at AstraZeneca PLC from 1999 to 2004, VP-General Medicines & Emerging Markets at Sanofi from 2015 to 2017, Head-Bio Research & Development at Lonza AG from 2017 to 2020, and Director at BacThera AG from 2019 to 2020.
She also served as the Chief Business Officer at VectivBio Holding AG from 2020 to 2022.
Ms. Holland holds a graduate and doctorate degree from the University of Oxford and an MBA from Manchester Business School.
Aktive Positionen von Sarah Holland
| Unternehmen | Position | Beginn |
|---|---|---|
| Swiss Healthcare Licensing Group | Direktor/Vorstandsmitglied | 01.01.2019 |
Ehemalige bekannte Positionen von Sarah Holland
| Unternehmen | Position | Ende |
|---|---|---|
| VECTIVBIO HOLDING AG | Corporate Officer/Principal | 31.07.2022 |
BacThera AG
 BacThera AG Pharmaceuticals: MajorHealth Technology BacThera AG manufactures bio therapeutic products. The private company is based in Basel, Switzerland and has subsidiaries in Spain. The Swiss company was founded in 2019. Lukas Schüpbach has been the CEO of the company since 2020. | Direktor/Vorstandsmitglied | 01.09.2020 |
Lonza AG
 Lonza AG BiotechnologyHealth Technology Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland. | Corporate Officer/Principal | 01.02.2020 |
| SANOFI | Corporate Officer/Principal | 01.07.2017 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.12.2004 |
Ausbildung von Sarah Holland
| Manchester Business School | Masters Business Admin |
| University of Oxford | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| SANOFI | Health Technology |
| Private Unternehmen | 4 |
|---|---|
VectivBio Holding AG
 VectivBio Holding AG Pharmaceuticals: MajorHealth Technology VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. It operates through Switzerland, Canada, and the United States geographical segment. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland. | Health Technology |
BacThera AG
BacThera AG Pharmaceuticals: MajorHealth Technology BacThera AG manufactures bio therapeutic products. The private company is based in Basel, Switzerland and has subsidiaries in Spain. The Swiss company was founded in 2019. Lukas Schüpbach has been the CEO of the company since 2020. | Health Technology |
Lonza AG
Lonza AG BiotechnologyHealth Technology Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland. | Health Technology |
| Swiss Healthcare Licensing Group |
